PKM and diffuse large B-cell lymphoma: Another piece of evidence corroborating the implication of SMYD3 in cancer metabolism was that SMYD3 increased pyruvate kinase M2 (PKM2) expression to support a hyperproliferative phenotype in diffuse large B-cell lymphoma (DLBCL) [27].